Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2021 3
2022 3
2023 8
2024 22
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.
Ree IMC, de Haas M, van Geloven N, Juul SE, de Winter D, Verweij EJT, Oepkes D, van der Bom JG, Lopriore E. Ree IMC, et al. Among authors: verweij ejt. Lancet Haematol. 2023 Dec;10(12):e976-e984. doi: 10.1016/S2352-3026(23)00285-5. Lancet Haematol. 2023. PMID: 38030319 Clinical Trial.
Monoclonal RhD prophylaxis: high time to evaluate efficacy.
Verweij E, Tura AK, Gure T, Pyuza J, Mchome B, Kawaza K, Moons P, de Winter D, Van't Oever R, Spitalnik S, van der Schoot CE, van den Akker T; AFRICARhE consortium. Verweij E, et al. Lancet. 2024 Mar 2;403(10429):806-807. doi: 10.1016/S0140-6736(23)01888-3. Lancet. 2024. PMID: 38431342 No abstract available.
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.
Komatsu Y, Verweij EJTJ, Tiblad E, Lopriore E, Oepkes D, Agarwal P, Lam E, Leu JH, Ling LE, Nelson RM, Olusajo V, Saeed-Khawaja S, Tjoa ML, Zhou J, Amin U, Sirah W, Moise KJ. Komatsu Y, et al. Among authors: verweij ejtj. Am J Perinatol. 2024 Sep 17. doi: 10.1055/a-2404-8089. Online ahead of print. Am J Perinatol. 2024. PMID: 39197469 Free article.
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.
Sagar RL, Åström E, Chitty LS, Crowe B, David AL, DeVile C, Forsmark A, Franzen V, Hermeren G, Hill M, Johansson M, Lindemans C, Lindgren P, Nijhuis W, Oepkes D, Rehberg M, Sahlin NE, Sakkers R, Semler O, Sundin M, Walther-Jallow L, Verweij EJTJ, Westgren M, Götherström C. Sagar RL, et al. Among authors: verweij ejtj. BMJ Open. 2024 Jun 4;14(6):e079767. doi: 10.1136/bmjopen-2023-079767. BMJ Open. 2024. PMID: 38834319 Free PMC article.
Lactate acidosis and hypoglycaemia in twin anaemia polycythemia sequence donors.
van de Sande MJA, Lopriore E, Verweij EJT, de Bruin C, Slaghekke F, Tollenaar LSA. van de Sande MJA, et al. Among authors: verweij ejt. Arch Dis Child Fetal Neonatal Ed. 2023 May;108(3):320-321. doi: 10.1136/archdischild-2022-323964. Epub 2022 Jul 4. Arch Dis Child Fetal Neonatal Ed. 2023. PMID: 35788032 No abstract available.
33 results